glp-1 drug class Dosage of analogues GLP-1 Drug Comparison in Diabetes

CMSs efforts to expand Medicare coverage of GLP-1s for obesity could provide substantial benefits to millions of Medicare beneficiaries, given the potential demand for these highly effective medicationsThere are potential drawbacks to the short-term program, however.

Many drugs are in the pipeline for the treatment of NAFLD/NASH, and several glucose-lowering drugs are now being tested specifically for the treatment of liver disease

Includes medication, clinician care, 1:1 coaching & Noom Weight program

ANALYSIS METHODOLOGY For a deeper understanding of where off-label GLP-1 uses are emerging, Storyful Intelligence analyzed 29.9k mentions across conversations on X, Facebook, Reddit, and Instagram, from February 1, 2024, to March 24, 2025

The dual GIP/GLP-1 receptor agonist tirzepatide is among the furthest developed multi-agonists for diabetes care and has so far displayed promising nephroprotective effects

Ozempic and other GLP-1 receptor agonists have rapidly become some of the most talked-about medications in the management of type 2 diabetes and weight-relat...